PERCEPTIVE ADVISORS LLC Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$5.8B
Holdings
108
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (108 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 10,794,876 | $456.3B | 7924.67% | |
| 2 | AM6AMICUS THERAPEUTICS INC | 28,057,456 | $330.5B | 5740.17% | |
| 3 | IOVAIOVANCE BIOTHERAPEUTICS INC | 19,272,991 | $285.6B | 4960.54% | |
| 4 | ACLXARCELLX INC | 3,933,556 | $273.6B | 4751.32% | |
| 5 | NUVLNUVALENT INC | 2,783,454 | $209.0B | 3629.93% | |
| 6 | APGEAPOGEE THERAPEUTICS INC | 2,699,345 | $179.4B | 3115.19% | |
| 7 | INBXUSDINHIBRX INC | 4,256,104 | $148.8B | 2584.13% | |
| 8 | —FUSION PHARMACEUTICALS INC | 6,825,395 | $145.5B | 2527.24% | |
| 9 | RYTMRHYTHM PHARMACEUTICALS INC | 3,268,579 | $141.6B | 2459.68% | |
| 10 | PCVXVAXCYTE INC | 1,932,759 | $132.0B | 2292.94% | |
| 11 | SLNOSOLENO THERAPEUTICS INC | 3,074,542 | $131.6B | 2285.37% | |
| 12 | MDTMEDTRONIC PLC | 1,429,563 | $124.6B | 2163.73% | |
| 13 | MDGLMADRIGAL PHARMACEUTICALS INC | 429,953 | $114.8B | 1994.02% | |
| 14 | SWTXSPRINGWORKS THERAPEUTICS INC | 2,262,462 | $111.4B | 1933.99% | |
| 15 | NBIXNEUROCRINE BIOSCIENCES INC | 804,409 | $110.9B | 1926.80% | |
| 16 | IMVTIMMUNOVANT INC | 3,063,212 | $99.0B | 1718.88% | Call |
| 17 | SYRESPYRE THERAPEUTICS INC | 2,556,679 | $97.0B | 1684.19% | |
| 18 | BHVNBIOHAVEN LTD | 1,725,047 | $94.3B | 1638.48% | |
| 19 | SLDBSOLID BIOSCIENCES INC | 6,906,646 | $92.0B | 1597.73% | |
| 20 | CATBUSDASTRIA THERAPEUTICS INC | 6,485,420 | $91.2B | 1584.76% | |
| 21 | AXSMAXSOME THERAPEUTICS INC | 1,105,341 | $88.2B | 1531.90% | |
| 22 | VKTXVIKING THERAPEUTICS INC | 994,098 | $81.5B | 1415.71% | |
| 23 | EOLSEVOLUS INC | 5,753,798 | $80.6B | 1398.99% | |
| 24 | LYRALYRA THERAPEUTICS INC | 12,757,562 | $79.4B | 1378.13% | |
| 25 | IRONDISC MEDICINE INC | 1,239,866 | $77.2B | 1340.65% | Put |
| 26 | CRGXCARGO THERAPEUTICS INC | 3,448,004 | $77.0B | 1336.58% | |
| 27 | ITCIEURINTRA-CELLULAR THERAPIES INC | 1,055,355 | $73.0B | 1268.34% | |
| 28 | NTRANATERA INC | 757,225 | $69.3B | 1202.78% | |
| 29 | CRNXCRINETICS PHARMACEUTICALS IN | 1,476,203 | $69.1B | 1200.10% | |
| 30 | MGTXMEIRAGTX HLDGS PLC | 11,331,103 | $68.7B | 1193.54% | |
| 31 | SRPTSAREPTA THERAPEUTICS INC | 525,683 | $68.1B | 1181.93% | |
| 32 | VRDNVIRIDIAN THERAPEUTICS INC | 3,657,099 | $64.0B | 1112.13% | |
| 33 | VRNAVERONA PHARMA PLC | 3,761,576 | $60.5B | 1051.13% | |
| 34 | APLTAPPLIED THERAPEUTICS INC | 8,505,000 | $57.8B | 1004.42% | Call |
| 35 | CGONCG ONCOLOGY INC | 1,304,105 | $57.3B | 994.28% | |
| 36 | AORTARTIVION INC | 2,668,978 | $56.5B | 980.83% | |
| 37 | ARVNARVINAS INC | 1,236,603 | $51.0B | 886.55% | |
| 38 | CELCCELCUITY INC | 2,362,279 | $51.0B | 886.17% | |
| 39 | PRAXPRAXIS PRECISION MEDICINES I | 821,589 | $50.1B | 870.68% | |
| 40 | RCKTROCKET PHARMACEUTICALS INC | 1,801,068 | $48.5B | 842.67% | |
| 41 | IMTXIMMATICS N.V | 4,582,409 | $48.2B | 836.43% | |
| 42 | TARSTARSUS PHARMACEUTICALS INC | 1,296,416 | $47.1B | 818.43% | |
| 43 | BBIOBRIDGEBIO PHARMA INC | 1,412,033 | $43.7B | 758.26% | |
| 44 | ADMAADMA BIOLOGICS INC | 6,433,369 | $42.5B | 737.42% | |
| 45 | EWTXEDGEWISE THERAPEUTICS INC | 2,319,646 | $42.3B | 734.82% | |
| 46 | VRCAVERRICA PHARMACEUTICALS INC | 7,099,182 | $42.0B | 729.90% | |
| 47 | ISRGINTUITIVE SURGICAL INC | 101,800 | $40.6B | 705.59% | |
| 48 | XENEXENON PHARMACEUTICALS INC | 892,208 | $38.4B | 667.07% | |
| 49 | NAUTNAUTILUS BIOTECHNOLOGY INC | 12,594,211 | $37.0B | 643.06% | |
| 50 | AKROAKERO THERAPEUTICS INC | 1,387,471 | $35.0B | 608.68% | |
| 51 | CNTACENTESSA PHARMACEUTICALS PLC | 3,083,307 | $34.8B | 605.10% | |
| 52 | LABPLANDOS BIOPHARMA INC | 1,486,991 | $31.9B | 554.72% | |
| 53 | OCULOCULAR THERAPEUTIX INC | 3,324,468 | $30.3B | 525.41% | |
| 54 | TMCITREACE MED CONCEPTS INC | 2,304,954 | $30.1B | 522.40% | |
| 55 | CABACABALETTA BIO INC | 1,716,660 | $29.3B | 508.62% | |
| 56 | PTGXPROTAGONIST THERAPEUTICS INC | 994,323 | $28.8B | 499.58% | |
| 57 | IRTCIRHYTHM TECHNOLOGIES INC | 245,205 | $28.4B | 493.99% | |
| 58 | ALDXALDEYRA THERAPEUTICS INC | 8,593,586 | $28.1B | 488.04% | |
| 59 | AUTLAUTOLUS THERAPEUTICS PLC | 4,330,745 | $27.6B | 479.86% | |
| 60 | ACRVACRIVON THERAPEUTICS INC | 3,007,858 | $21.5B | 373.50% | |
| 61 | PEPGPEPGEN INC | 1,410,438 | $20.7B | 360.08% | |
| 62 | RVMDREVOLUTION MEDICINES INC | 618,885 | $19.9B | 346.42% | |
| 63 | ABBVABBVIE INC | 106,500 | $19.4B | 336.81% | |
| 64 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 339,012 | $17.0B | 295.74% | |
| 65 | ENGNENGENE HOLDINGS INC | 998,888 | $16.9B | 294.05% | |
| 66 | LIVNLIVANOVA PLC | 299,000 | $16.7B | 290.49% | |
| 67 | —ATHIRA PHARMA INC | 5,402,964 | $14.8B | 257.11% | |
| 68 | TCMDTACTILE SYS TECHNOLOGY INC | 903,085 | $14.7B | 254.87% | |
| 69 | OBIOORCHESTRA BIOMED HLDGS INC | 2,545,881 | $13.4B | 233.01% | |
| 70 | AXGNAXOGEN INC | 1,553,929 | $12.5B | 217.79% | |
| 71 | EYPTEYEPOINT PHARMACEUTICALS INC | 589,646 | $12.2B | 211.67% | |
| 72 | ZYMEZYMEWORKS INC | 1,074,807 | $11.3B | 196.37% | |
| 73 | RAPTEURRAPT THERAPEUTICS INC | 1,223,472 | $11.0B | 190.81% | |
| 74 | TYRATYRA BIOSCIENCES INC | 669,159 | $11.0B | 190.59% | |
| 75 | PRCTPROCEPT BIOROBOTICS CORP | 210,659 | $10.4B | 180.81% | |
| 76 | MORFMORPHIC HLDG INC | 288,221 | $10.1B | 176.20% | |
| 77 | SPRYARS PHARMACEUTICALS INC | 867,319 | $8.9B | 153.94% | |
| 78 | ARQTARCUTIS BIOTHERAPEUTICS INC | 750,000 | $7.4B | 129.08% | |
| 79 | AVBPARRIVENT BIOPHARMA INC | 415,000 | $7.4B | 128.72% | |
| 80 | DTILPRECISION BIOSCIENCES INC | 480,483 | $6.5B | 113.15% | |
| 81 | COGTCOGENT BIOSCIENCES INC | 883,333 | $5.9B | 103.09% | |
| 82 | KALVKALVISTA PHARMACEUTICALS INC | 500,000 | $5.9B | 102.99% | |
| 83 | IBRXIMMUNITYBIO INC | 1,052,887 | $5.7B | 98.19% | |
| 84 | AMLXAMYLYX PHARMACEUTICALS INC | 1,979,125 | $5.6B | 97.62% | Call |
| 85 | MGNXMACROGENICS INC | 378,327 | $5.6B | 96.72% | |
| 86 | HLXCHELIX ACQUISITION CORP II | 500,000 | $5.2B | 90.31% | |
| 87 | ASNSUSDX4 PHARMACEUTICALS INC | 3,545,454 | $4.9B | 85.59% | |
| 88 | XBISPDR SER TR | 50,000 | $4.7B | 82.40% | Put |
| 89 | ESTAESTABLISHMENT LABS HLDGS INC | 82,299 | $4.2B | 72.75% | |
| 90 | NAMSNEWAMSTERDAM PHARMA COMPANY | 175,000 | $4.1B | 71.88% | |
| 91 | ABSIABSCI CORPORATION | 700,000 | $4.0B | 69.05% | |
| 92 | VERUEURVERU INC | 5,584,699 | $3.9B | 67.90% | |
| 93 | KYTXKYVERNA THERAPEUTICS INC | 150,000 | $3.7B | 64.71% | |
| 94 | TRIBTRINITY BIOTECH PLC | 1,800,000 | $3.7B | 63.77% | |
| 95 | NBTXNANOBIOTIX | 555,066 | $3.6B | 62.66% | |
| 96 | NVNOENVVENO MEDICAL CORPORATION | 623,315 | $3.4B | 58.89% | |
| 97 | NVV1NOVAVAX INC | 700,000 | $3.3B | 58.11% | Put |
| 98 | RVNCEURREVANCE THERAPEUTICS INC | 600,000 | $3.0B | 51.27% | |
| 99 | AGIOAGIOS PHARMACEUTICALS INC | 100,000 | $2.9B | 50.78% | Call |
| 100 | TOCAEURFORTE BIOSCIENCES INC | 3,265,359 | $2.3B | 39.48% |
Page 1 of 2Next